Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline

Speiser, Phyllis; Arlt, Wiebke; J. Auchus, Richard; S. Baskin, Laurence; S. Conway, Gerard; P. Merke, Deborah; F. L. Meyer‐Bahlburg, Heino; L. Miller, Walter; Hassan Murad, M.; E. Oberfield, Sharon; C. White, Perrin

doi:10.1210/jc.2018-01865

Public

Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline

Published in The Journal of Clinical Endocrinology & Metabolism • Sep 27, 2018

Authors:

Phyllis Speiser

Wiebke Arlt

Richard J. Auchus

Abstract

Newborn screening Cost-effectiveness 1.1 We recommend that all newborn screening programs incorporate screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. (1|s) 1.2 We recommend that first-tier screens use 17hydroxyprogesterone assays standardized to a common technology wit...

Subject

Congenital adrenal hyperplasia

Guideline

Endocrine system

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!